Ayahuasca Retreat Linked to Gut Health Shifts and PTSD Relief

A week-long ceremonial retreat centered around the traditional Amazonian brew ayahuasca was associated with marked reductions in trauma symptoms alongside beneficial shifts in the human digestive tract, according to an observational study published in the journal Brain Behavior and Immunity Integrative. The findings offer early clues into how the biological dialogue between the digestive system and the brain may reflect or support psychological recovery.

A Dual Shift in Mental Health and Gut Biology

Following three ceremonial sessions with ayahuasca—a psychoactive botanical concoction traditionally utilized in South American indigenous healing practices—attendees reported meaningful relief from trauma-related distress. Scores on the PTSD Checklist for DSM-5 (PCL-5) dropped considerably relative to pre-retreat baselines, suggesting a rapid easing of post-traumatic stress disorder symptoms.

Alongside symptom relief, psychological evaluations tracked broad personality transformations across the Five-Factor Model. Participants experienced a significant decrease in neuroticism, the trait reflecting a tendency toward negative emotions and psychological vulnerability. Concurrently, researchers recorded measurable increases in openness, conscientiousness, extraversion, and agreeableness, indicating an overall boost in emotional resilience and social adaptability.

Changes in the Microbiome-Gut-Brain Axis

The observed mental health benefits coincided with compositional changes in the microbiome-gut-brain axis, the complex communication network connecting the central nervous system to gastrointestinal microbes. When evaluating alpha diversity—a metric describing the overall richness and evenness of microbial species within an individual—researchers found no statistically significant alterations between pre- and post-retreat samples.

However, beta diversity analyses, which assess differences in overall microbial community structure between timepoints, revealed a clear within-subject shift by the end of the retreat. Most notably, the investigators identified an increased relative abundance of bacteria known for synthesizing short-chain fatty acids (SCFAs). These enriched microbes included Blautia, Oscillospira, Colidextribacter, and Lachnospiraceae UCG-004, bacterial groups widely recognized for supporting gut barrier integrity, metabolic function, and anti-inflammatory signaling.

How the Study Was Conducted

To examine these interconnected systems, the researchers conducted an observational, single-arm study tracking 22 adult participants during an international retreat. The volunteer cohort consisted of both U.S. military veterans and non-veterans who presented with varying degrees of baseline PTSD severity. Over the seven-day period, participants took part in three guided ayahuasca ceremonies.

The team collected clinical inventories and biological samples immediately before and after the retreat experience. Gut microbiome community structures and diversity metrics were evaluated by performing 16S rRNA gene amplicon sequencing on participant fecal samples, allowing the researchers to compare changes in bacterial taxa directly against shifts in standardized personality and PTSD self-assessments.

Preliminary Evidence and Necessary Next Steps

While the parallel improvements in psychological health and gut bacterial profiles are promising, the authors emphasize that the study remains preliminary. Because the investigation was a small, open-label observational project without a non-ayahuasca control group, it cannot prove that the psychedelic brew directly caused the psychological or microbial shifts. Confounding elements such as communal bonding, changes in diet, travel, novel environments, and intensive emotional integration may have contributed significantly to the outcomes.

Consequently, the researchers stress that future large-scale, randomized, double-blind, placebo-controlled clinical trials will be essential to establish causality. Such rigorous trials could clarify whether changes in the gut microbiome represent an active therapeutic mechanism or a downstream biological marker of psychedelic-assisted mental health recovery.

---